LU75229A1 - - Google Patents

Info

Publication number
LU75229A1
LU75229A1 LU75229A LU75229A LU75229A1 LU 75229 A1 LU75229 A1 LU 75229A1 LU 75229 A LU75229 A LU 75229A LU 75229 A LU75229 A LU 75229A LU 75229 A1 LU75229 A1 LU 75229A1
Authority
LU
Luxembourg
Application number
LU75229A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75229A1 publication Critical patent/LU75229A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU75229A 1975-06-25 1976-06-24 LU75229A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752528879 DE2528879A1 (de) 1975-06-25 1975-06-25 11 beta-fluor-androstene

Publications (1)

Publication Number Publication Date
LU75229A1 true LU75229A1 (de) 1977-02-18

Family

ID=5950147

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75229A LU75229A1 (de) 1975-06-25 1976-06-24

Country Status (8)

Country Link
JP (1) JPS523050A (de)
BE (1) BE843437A (de)
DD (1) DD124988A5 (de)
DE (1) DE2528879A1 (de)
DK (1) DK252276A (de)
FR (1) FR2316958A1 (de)
LU (1) LU75229A1 (de)
NL (1) NL7606822A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439487A (en) * 1982-12-17 1984-03-27 E. I. Du Pont De Nemours & Company Polyester/nylon bicomponent flament

Also Published As

Publication number Publication date
NL7606822A (nl) 1976-12-28
BE843437A (fr) 1976-12-27
JPS523050A (en) 1977-01-11
FR2316958A1 (fr) 1977-02-04
DD124988A5 (de) 1977-03-23
DK252276A (da) 1976-12-26
DE2528879A1 (de) 1977-01-13

Similar Documents

Publication Publication Date Title
JPS51112465U (de)
JPS51105208U (de)
CH585472A5 (de)
BG21908A1 (de)
CH304475A4 (de)
CH579725A5 (de)
CH579837A5 (de)
CH583651A5 (de)
CH586052A5 (de)
CH586682A5 (de)
CH588681A5 (de)
CH589817A5 (de)
CH590099A5 (de)
CH591073A5 (de)
CH591103A5 (de)
CH591902A5 (de)
CH592426A5 (de)
CH593769A5 (de)
CH593771A5 (de)
CH594759A5 (de)
CH595421A5 (de)
CH595597A5 (de)
CH595733A5 (de)
CH595916A5 (de)
CH595917A5 (de)